ModelEdge

Navidea Biopharmaceuticals, Inc.
NAVB
Filing Type8-K
Filing Date11/15/2023
Updated11/16/23, 9:55 AM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Shareholder votes
EX-10.1EXHIBIT 10.1